uk society for behavioural medicine · uk society for behavioural medicine 9th annual scientific...
TRANSCRIPT
NPRI
UK Society for Behavioural Medicine 9th Annual Scientific Meeting
“Behavioural Medicine: From Laboratory to Policy”
University of Oxford Examination Schools
Monday 9 and Tuesday 10 December 2013
NPRI
UK Society for Behavioural Medicine 9th Annual Scientific Meeting
“Behavioural Medicine: From Laboratory to Policy”
Parallel Session E Weight mangagement, and
physical activity, part 2
14.25-15.40
Chaired by Jamie Hartmann-Boyce
NPRI
UK Society for Behavioural Medicine 9th Annual Scientific Meeting
“Behavioural Medicine: From Laboratory to Policy”
The impact of a weight loss intervention
(BeWEL) initiated through a national
colorectal cancer screening programme
Annie Anderson
Annie S. Anderson, A.Craigie, S. Caswell, M. Macleod
The BeWEL team Centre for Research into Cancer Prevention and
Screening
University of Dundee
The impact of a weight loss
programme (BeWEL) initiated
through a national colorectal cancer
screening programme
• Prof Annie Anderson (PI)
• Prof Robert Steele
• Dr Shaun Treweek
• Prof Jill Belch
• Dr Fergus Daly
University of Dundee
• Prof Jane Wardle
University College London
• Prof Anne Ludbrook
University of Aberdeen
• Dr Martine Stead
University of Stirling
• Dr Alison Kirk
University of Strathclyde
National Prevention Research
Initiative (MRC)
• Joyce Thompson
• Jackie Rodger
NHS Tayside
• Tayside
• Prof Robert Steele
• Ayrshire & Arran
• Mr Robert Diament
• Forth Valley
• Mr Wilson Hendry
• Greater Glasgow and Clyde
• Mr Derek Gillon
NHS Site Collaborators
Preventability estimates (PAF%) for cancers
of the colon and rectum (UK) (WCRF, 2013)
and Parkin (2011)
Exposure WCRF PAF%
Parkin PAF%
Foods containing Fibre 12 12
Red meat 5 21 (combined)
Processed meat 10
Alcoholic drinks 7 12
Physical Activity 12 3
Body Fatness 14 13
Total estimate 47 48
Changing Cancer Risk Byers & Sedjo (2011) Diabetes Obes Metab
Dietary RCT’s Site Populati
on
Body
weight
loss
Cancer
risk
reduction
Sjostrom et al
(2009)
All sites Women
Men
31.9%
19.3%
42%
3%
Adams et al (2009) All sites Women
Men
31.0% 24%
2%
Christou et al (2008) All sites Men &
Women
31.9% 78%
Bariatric Surgery Cohorts
Observational data suggest wt decreases incidence in CRC in men (Rapp et al. 2008)
The effect of Body Weight Reduction on
the incidence of Colorectal adenoma
Subjects Adenoma Incidence %
Weight gain/maintenance 2418 413 17.1 **
Weight loss 150 14 9.3
Total 2568 427 16.6
** p<0.01
Incidence after 1 year according to weight change:
Yamaji et al, (2008) Am J Gastroenterol (103) 2061-2067
Colonoscopy
Removing the adenoma removes the immediate risk of disease
The underlying factors which might influence the development of adenoma remain
Study design
3.5 year study (start 1st Feb 2010)
Two-arm multi-centre RCT
Hospital setting across 4 sites
n=316 randomised (158 / group):
– 12 month BeWEL intervention
– Usual care
6 months 24 months 6 months
Pre-trial development
Recruitment, data collection & intervention
implementation
Final data collection, analysis &
interpretation
Formative research
Using the teachable moment…..
Patients need to
– Be aware of the risk factors for adenoma
– Be able to relate these to personal behaviours
– To have a shared and accepted understanding of lifestyle and CRC
Importance of consultant endorsement
Baseline assessments
Randomisation
Intervention Group Comparison Group
12 month follow up
Exit interview
Full invitation from research nurse:
Sent within next 2 weeks
3 month follow up
Colonoscopy results sent by post
+ “Teaser Letter” from consultant endorsing study
Study
Procedures
BeWEL
12-month
programme
Outcome measures
• Change in body weight (not adenoma recurrence)
Primary outcome
• Change in:
• Waist circumference
• Cardiovascular risk factors (BP, lipids)
• Metabolic risk factors (glucose, HbA1c, insulin)
• Dietary intake (DINE)
• Physical activity (Accelerometry)
• Self assessed general health (SFQ12)
• Self-efficacy
• Programme acceptability to participants and staff
• Intervention cost
Secondary outcomes
Intervention design
Based on Diabetes Prevention Programme:
Target 7% weight loss:
• -600 kcal/day deficit diet
• Red and processed meat portions (animal fats)
• Alcohol
• Portion sizes
• Increase wholegrains, vegetables and fruit
• Increased mod / vig activity to 150 mins / week
Intervention delivery
• Combine knowledge, motivation and
• Behavioural techniques
• Motivational interviewing
• Goal setting
• Implementation intentions
• Self monitoring and feedback
• Re-enforcement
Behavioural and Re-enforcement techniques
for promoting change weight management
Self monitoring record book Body weight scales
Remind about 12 month goal, self monitoring records,
telephone calls and visits
Demonstrate and also
discuss body fat Explain recording and reporting
Inclusion criteria
Colorectal adenoma detected following
national FOBT screening
Age 50 to 74 (screening age in Scotland)
BMI >25 kg/m2
NO known cancer, insulin dependent DM
or pregnancy
Dose
All face to face contacts in months 1 to 3
– Delivered by Lifestyle counsellor
Foster immediate changes
Take 3 months to establish initial changes and build on
Monthly Telephone contacts thereafter
Baseline 12 months 3 months
Face-to-face
consultations
9 telephone consultations
BeWEL Recruitment – people are interested in
lifestyle intervention
Adults screened positive for adenoma aged 50 to 74 years
(n=997)
Responded ‘No’ n= 345 (35%)
Did not respond n=160 (16%)
Responded ‘Yes’ n=492 (49%) Changed mind
n=42 (9%)
Ineligible
1. BMI <25kg/m2 n=108(22%)
2. ‘Yes’ ineligible as reply
received after study closing
to recruitment n=13(3%)
Randomised n=329
BeWEL Retention – people stay with the
lifestyle intervention (91% follow up) for 12m
Allocated to intervention (n=163) Allocated to control (n=166)
3 month follow-up (n=153) 3 month follow-up (n=161)
12 month loss to
follow-up (n=9) 12 month loss to
follow-up (n=15)
12 month follow-up
(n=148) 91%
12 month follow-up
(n=157) 95%
Baseline and Clinical Characteristics at Randomisation
Intervention
(n=163)
Control
(n=166)
All
(n=329)
Age (years)
Range
63.5 7.0
50 – 75
63.6 6.7
50 – 75
63.6 6.8
50 – 75
Male gender 120 (73.6%) 123 (74.1%) 243 (73.9%)
Employment status
Retired
Employed full-time
Employed part-time
Unemployed
Other
90 (55.2%)
45 (27.6%)
18 (11.0%)
2 (1.2%)
8 (4.9%)
97 (58.4%)
41 (24.7%)
14 (8.4%)
10 (6.0%)
4 (2.4%)
187 (56.8%)
86 (26.1%)
32 (9.7%)
12 (3.6%)
12 (3.6%)
SIMD* (quintiles)
1 (most deprived)
2
3
4
5 (least deprived)
25 (15.3%)
33 (20.2%)
26 (16.0%)
39 (23.9%)
40 (24.5%)
29 (17.5%)
28 (16.9%)
33 (19.9%)
45 (27.1%)
31 (18.7%)
54 (16.4%)
61 (18.5%)
59 (17.9%)
84 (25.5%)
71 (21.6%)
Data are mean ± SD or number (%) unless stated otherwise. *Scottish Index of Multiple Deprivation
Intervention
Group
Control Group
P
n Mean ± SD n Mean ± SD
Bodyweight (kg)
Baseline 163 90.2± 14.9 166 88.4± 14.3
<0.0001 12 months 148 87.2± 15.7 157 88.1± 14.2
Difference 148 -3.50 ± 4.9 157 -0.78 ± 3.8
Weight loss (%) 12 months 148 -3.92 ± 5.4 157 -0.83 ± 4.1 <0.001
Waist
Circumference (cm)
Baseline 163 104.7 ± 10.9
166 103.9 ± 10.9
<0.0001
12 months 145 100.2 ± 12.0 157 102.1 ± 11.1
Difference 145 -4.91 ± 5.4 157 -2.16 ± 4.4
Changes in anthropometric measures from
baseline at 12 months by treatment group
Body Weight Reduction
% achieving 5% body weight loss
– Significantly higher in the intervention group
than the control group (36% vs. 12%)
% achieving 7% body weight loss
– Also higher in the intervention group (22% vs.
9%)
Intervention
Group
Control Group
P
n Mean ± SD n Mean ± SD
Glucose
(mmol/l)
Baseline 142 6.11± 2.0 149 6.12± 1.9
0.05 12 months 125 5.68± 1.4 132 6.08± 1.7
Difference 125 -0.27± 1.9 132 -0.07± 1.0
Insulin
(mmol/l)
Baseline 104 11.12± 8.3 110 10.17± 8.8
0.82 12 months 74 12.77± 11.1 79 13.48± 10.2
Difference 66 2.77± 9.00 73 2.58± 7.1
HbA1c (%)
Baseline 149 6.02± 1.2 151 6.03± 1.2
0.06 12 months 120 5.84± 0.8 129 6.03± 1.0
Difference 120 -0.13± 0.9 129 -0.02± 0.6
Glucose metabolism biomarkers
Intervention
Group
Control Group
P
n Mean± SD n Mean± SD
Fat
consumption
score*
Baseline 163 30± 10.6 166 32± 10.6
<0.0001 12 months 146 24± 7.4 156 28±10.3
Difference 146 -7.3± 10.2 156 -3.8± 8.0
Fruit and
vegetable
(p/day)
Baseline 163 4± 2.2 166 4± 2.2
0.0004 12 months 148 5± 2.4 157 4± 2.4
Difference 148 0.6± 2.3 157 0.0± 2.1
Changes in dietary intake
*Based on intakes of foods which contribute substantially to fat intake i.e. dairy
foods, meat, processed meat, fish, fried foods, sweet and savoury snacks and fat
spreads. . A score of less than 30 is equivalent to around 83g fat (estimate 35% of total energy intake for an average woman).
Intervention Group Control Group
P n Mean± SD n Mean± SD
Daily average
time spent
active (mins)
Baseline 156 82± 62.3 157 79± 55.9
0.02 12 months 140 89± 65.3 148 74± 62.0
Difference 140 6.23± 60.1 148 -5.53± 40.0
Daily average
time spent in
moderate
activity (mins)
Baseline 153 81± 58.0 153 77± 53.7
0.05 12 months 137 86± 63.4 144 73± 60.7
Difference 137 6.27± 54.5 144 -3.67± 38.5
Daily average
step count
Baseline 156 8429± 3995 157 7734± 3538
0.03 12 months 140 8697± 4404 148 7460± 3873
Difference 140 239.6± 3118.3 148 -310.2± 2263.6
Changes in Physical Activity
Participant experience
spoke highly of the study + counselling staff
feeling of being understood as an individual
(encouraging and maintaining involvement)
several felt they would not have engaged so
well in a group setting
motivations varied: small "scare“/ adenoma
+ other triggers/ “if not now, when”?
successful weight loss - sustained
commitment/strategies to deal with relapse
triggers.
Conclusions
There is interest in lifestyle change in people
with CRC adenomas
Study participants show commitment to lifestyle
change over a 12 month period
Study participants respond favourably to lifestyle
interventions
Considerable potential for disease risk reduction
in older adults
Colorectal cancer screening and prevention
programme?